Literature DB >> 30889376

Therapeutic Clues from an Integrated Omic Assessment of East Asian Triple Negative Breast Cancers.

Laura M Heiser1, Gordon B Mills2, Joe W Gray3.   

Abstract

In this issue of Cancer Cell, Jiang et al. report a genomic and transcriptional analysis of triple negative breast cancers (TNBCs) from an East Asian population. Their study shows minor differences with published studies of European and North American populations and suggests a therapeutic decision tree for treatment of TNBC.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2019        PMID： 30889376      PMCID： PMC6499473          DOI： 10.1016/j.ccell.2019.02.012

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  10 in total

1.  Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies.

Authors:  Yi-Zhou Jiang; Ding Ma; Chen Suo; Jinxiu Shi; Mengzhu Xue; Xin Hu; Yi Xiao; Ke-Da Yu; Yi-Rong Liu; Ying Yu; Yuanting Zheng; Xiangnan Li; Chenhui Zhang; Pengchen Hu; Jing Zhang; Qi Hua; Jiyang Zhang; Wanwan Hou; Luyao Ren; Ding Bao; Bingying Li; Jingcheng Yang; Ling Yao; Wen-Jia Zuo; Shen Zhao; Yue Gong; Yi-Xing Ren; Ya-Xin Zhao; Yun-Song Yang; Zhenmin Niu; Zhi-Gang Cao; Daniel G Stover; Claire Verschraegen; Virginia Kaklamani; Anneleen Daemen; John R Benson; Kazuaki Takabe; Fan Bai; Da-Qiang Li; Peng Wang; Leming Shi; Wei Huang; Zhi-Ming Shao
Journal:  Cancer Cell       Date:  2019-03-07       Impact factor: 31.743

Review 2.  Subtyping of triple-negative breast cancer: implications for therapy.

Authors:  Vandana G Abramson; Brian D Lehmann; Tarah J Ballinger; Jennifer A Pietenpol
Journal:  Cancer       Date:  2014-07-16       Impact factor: 6.860

3.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

4.  Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas.

Authors:  Dezheng Huo; Hai Hu; Suhn K Rhie; Eric R Gamazon; Andrew D Cherniack; Jianfang Liu; Toshio F Yoshimatsu; Jason J Pitt; Katherine A Hoadley; Melissa Troester; Yuanbin Ru; Tara Lichtenberg; Lori A Sturtz; Carl S Shelley; Christopher C Benz; Gordon B Mills; Peter W Laird; Craig D Shriver; Charles M Perou; Olufunmilayo I Olopade
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

5.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.

Authors:  Christina Curtis; Sohrab P Shah; Suet-Feung Chin; Gulisa Turashvili; Oscar M Rueda; Mark J Dunning; Doug Speed; Andy G Lynch; Shamith Samarajiwa; Yinyin Yuan; Stefan Gräf; Gavin Ha; Gholamreza Haffari; Ali Bashashati; Roslin Russell; Steven McKinney; Anita Langerød; Andrew Green; Elena Provenzano; Gordon Wishart; Sarah Pinder; Peter Watson; Florian Markowetz; Leigh Murphy; Ian Ellis; Arnie Purushotham; Anne-Lise Børresen-Dale; James D Brenton; Simon Tavaré; Carlos Caldas; Samuel Aparicio
Journal:  Nature       Date:  2012-04-18       Impact factor: 49.962

6.  Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity.

Authors:  Yuan Chun Ding; Linda Steele; Charles Warden; Sharon Wilczynski; Joanne Mortimer; Yuan Yuan; Susan L Neuhausen
Journal:  Oncotarget       Date:  2019-01-04

7.  Comprehensive molecular portraits of human breast tumours.

Authors: 
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

8.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

9.  PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors.

Authors:  Brian D Lehmann; Joshua A Bauer; Johanna M Schafer; Christopher S Pendleton; Luojia Tang; Kimberly C Johnson; Xi Chen; Justin M Balko; Henry Gómez; Carlos L Arteaga; Gordon B Mills; Melinda E Sanders; Jennifer A Pietenpol
Journal:  Breast Cancer Res       Date:  2014-08-08       Impact factor: 6.466

10.  Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.

Authors:  Brian D Lehmann; Bojana Jovanović; Xi Chen; Monica V Estrada; Kimberly N Johnson; Yu Shyr; Harold L Moses; Melinda E Sanders; Jennifer A Pietenpol
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.